News for Alkermes plc (ALKS)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

We recently published a list of Billionaire Jim Simons’ RenTech’s 10 Small-Cap Stock Picks with Huge Upside Potential.

Jim Simons was (and still is even after his death in May 2024) one of the biggest names – if not the biggest – in the hedge fund space.

Significant Transaction by BlackRock, Inc. (Trades, Portfolio) On March 31, 2025, BlackRock, Inc. (Trades, Portfolio) executed a notable transaction involving A

Alkermes has a huge opportunity to expand its label to include pediatric patients with Schizophrenia and bipolar I disorder. Click to read my ALKS analysis.

While the top- and bottom-line numbers for Alkermes (ALKS) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

PR NewswireDUBLIN, May 1, 2025 ”” First Quarter Revenues of $306.5 Million ”””” GAAP Net Income of $22.5 Million and Diluted GAAP Earnings per Sha

Alkermes (ALKS) reported first-quarter revenue of $306.5 million, surpassing analysts' expectations of $304.11 million. This financial result lays a robust grou

Revenue: $306.5 million, surpassing the estimated $304.12 million.GAAP Net Income: $22.5 million, compared to $36.8 million in the same quarter last year.Dilut

Alkermes plc (ALKS) reported Q1 2025 revenue of $306.5 million, reflecting a 12.5% decrease compared to Q1 2024. The company achieved significant progre

PR NewswireDUBLIN, April 30, 2025 ”“ Survey Respondents Reported That AUD Diagnosis and Decision to Seek Treatment Were Driven by Negative Consequences of

Bitcoin breaks below $75,000 as crypto’s Trump rally fades, tariff turmoil. Tech bull Dan Ives slashes PT for Tesla, Apple over Trump's 'tariff armageddon.' Saudi Arabia slashes oil price.

**media[568275]**

Alkermes (ALKS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment.

**media[563710]**

Alkermes PLC (ALKS), a global biopharmaceutical company, announced on February 26, 2025, that its management team will participate in webcast fireside chats at

PR NewswireDUBLIN, Feb. 26, 2025 DUBLIN, Feb. 26, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in webc

The main growth driver for Alkermes going forward will be ALKS 2680. Read why I maintain my buy rating on ALKS stock.